Volker Lakner

757 total citations
7 papers, 451 citations indexed

About

Volker Lakner is a scholar working on Genetics, Oncology and Surgery. According to data from OpenAlex, Volker Lakner has authored 7 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Volker Lakner's work include Chronic Lymphocytic Leukemia Research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Volker Lakner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Volker Lakner collaborates with scholars based in Germany, Lithuania and Japan. Volker Lakner's co-authors include Gerhard Heil, Ingo Schwaner, Matthias Mölle, Tim F. Greten, Hanno Riess, Helmut Oettle, Bernd Dörken, Jörg Seraphin, Martin Görner and Jens Stieler and has published in prestigious journals such as Journal of Clinical Oncology, Endoscopy and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Volker Lakner

7 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volker Lakner Germany 5 385 157 122 115 114 7 451
James E. Krook United States 7 297 0.8× 110 0.7× 138 1.1× 92 0.8× 90 0.8× 9 427
Natalyn Hawk United States 9 432 1.1× 118 0.8× 175 1.4× 164 1.4× 91 0.8× 25 573
Catherine Jephcott United Kingdom 7 321 0.8× 121 0.8× 165 1.4× 120 1.0× 166 1.5× 10 443
Edith Brutcher United States 12 373 1.0× 108 0.7× 130 1.1× 122 1.1× 158 1.4× 20 498
Gordon E. Catton Canada 7 444 1.2× 141 0.9× 205 1.7× 179 1.6× 194 1.7× 7 519
Satoru Yasukawa Japan 13 221 0.6× 70 0.4× 129 1.1× 59 0.5× 157 1.4× 34 361
Y Matsuyama Japan 5 381 1.0× 190 1.2× 144 1.2× 138 1.2× 174 1.5× 8 486
Yoriko Takezako Japan 7 293 0.8× 77 0.5× 188 1.5× 97 0.8× 182 1.6× 13 408
J. Freilich United States 9 295 0.8× 110 0.7× 319 2.6× 96 0.8× 145 1.3× 18 509
Noël Stremsdoerfer France 5 517 1.3× 190 1.2× 311 2.5× 193 1.7× 166 1.5× 7 639

Countries citing papers authored by Volker Lakner

Since Specialization
Citations

This map shows the geographic impact of Volker Lakner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Lakner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Lakner more than expected).

Fields of papers citing papers by Volker Lakner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volker Lakner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Lakner. The network helps show where Volker Lakner may publish in the future.

Co-authorship network of co-authors of Volker Lakner

This figure shows the co-authorship network connecting the top 25 collaborators of Volker Lakner. A scholar is included among the top collaborators of Volker Lakner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volker Lakner. Volker Lakner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lange, Thoralf, Christian Niederwieser, Rainer Krahl, et al.. (2020). No advantage of Imatinib in combination with hydroxyurea over Imatinib monotherapy: a study of the East German Study Group (OSHO) and the German CML study group. Leukemia & lymphoma. 61(12). 2821–2830. 2 indexed citations
2.
Herold, Michael, Christian W. Scholz, Frank Rothmann, et al.. (2015). Long-term follow-up of rituximab plus first-line mitoxantrone, chlorambucil, prednisolone and interferon-alpha as maintenance therapy in follicular lymphoma. Journal of Cancer Research and Clinical Oncology. 141(9). 1689–1695. 5 indexed citations
3.
Oettle, Helmut, Hanno Riess, Jens Stieler, et al.. (2014). Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial. Journal of Clinical Oncology. 32(23). 2423–2429. 312 indexed citations
4.
Schäller, Gerhard, Ilka Fuchs, Jan Weber, et al.. (2007). Phase II Study of Capecitabine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer Pretreated With Anthracyclines or Taxanes. Journal of Clinical Oncology. 25(22). 3246–3250. 66 indexed citations
5.
Koenigsmann, Michael, Wolfgang Knauf, Michael Herold, et al.. (2004). Fludarabine and Bendamustine in Refractory and Relapsed Indolent Lymphoma—a Multicenter Phase I/II Trial of the East German Society of Hematology and Oncology (OSHO). Leukemia & lymphoma. 45(9). 1821–1827. 33 indexed citations
6.
Lakner, Volker, et al.. (1994). [Lymphatic outflow scintigraphy in a case of artificial edema of the lower limb].. PubMed. 33(6). 268–70. 1 indexed citations
7.
Arendt, Thomas, M Barten, Volker Lakner, & R Arendt. (1987). Diffuse Gastric Antral Vascular Ectasia: Cause of Chronic Gastrointestinal Blood Loss. Endoscopy. 19(5). 218–220. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James E. Krook Breakdown of academic impact, for papers by Natalyn Hawk Breakdown of academic impact, for papers by Catherine Jephcott Breakdown of academic impact, for papers by Edith Brutcher Breakdown of academic impact, for papers by Gordon E. Catton Breakdown of academic impact, for papers by Satoru Yasukawa Breakdown of academic impact, for papers by Y Matsuyama Breakdown of academic impact, for papers by Yoriko Takezako Breakdown of academic impact, for papers by J. Freilich Breakdown of academic impact, for papers by Noël Stremsdoerfer
Rankless by CCL
2026